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Humans are colonized by diverse populations of bacteria and
fungi when in a healthy state and in the settings of disease, and the
interactions between these microbial populations can be beneficial
or detrimental to the host [1]. Among these microbial populations,
Candida albicans is the fungus most commonly detected in
association with humans [2], and numerous studies have described
C. albicans interactions with its bacterial neighbors [1]. Here, with a
focus on C. albicans, we provide examples of how bacterial-fungal
interactions can influence human health. In addition, we highlight
studies that give insight into the molecular mechanisms that
govern the physical associations, interspecies communication, and
changes in microbial behavior and survival that occur when
bacteria and fungi occupy the same sites.
Bacterial2C. albicans Interactions Can Promote or
Prevent Disease
Bacterial and fungal co-infections have been implicated in
enhanced host colonization and virulence. For instance, C. albicans
and Escherichia coli exhibit a cooperative interaction wherein E. coli
enhances adhesion of C. albicans to bladder mucosa and increases
the likelihood of fungal urinary tract infections [3]. Likewise, the
risk of ventilator-associated pneumonia due to infection by
Pseudomonas aeruginosa is markedly greater in patients colonized by
C. albicans [4], and accordingly, antifungal treatments can reduce
the likelihood of developing this systemic disease [5]. Moreover,
denture stomatitis, an inflammation of the oral mucosa in denture
wearers, is influenced by the presence of C. albicans and other
oral microorganisms [6]. In fact, several studies demonstrate
an association between C. albicans and oral bacteria such as
Streptococcus (Figure 1A), Actinomyces, and Fusobacterium species [1,7],
and these physical interactions likely contribute to denture
colonization and oral candidiasis.
In contrast, lactic acid bacteria (Figure 1B), which normally
inhabit the intestinal and female reproductive tracts, compete with
C. albicans for adhesion sites and secrete substances that inhibit
fungal attachment to control C. albicans invasion and disease [8].
Interestingly, imbalance in the normal bacterial flora caused by
treatment with broad-spectrum antibiotics is a predisposing factor
associated with C. albicans colonization of immunocompromised
patients, probably due to decreased numbers of bacterial
competitors [9]. Thus, antibiotic therapies that specifically target
pathogens, in contrast to broad spectrum antibiotics, may help
prevent secondary problems that arise upon perturbation of
beneficial bacterial-fungal interactions.
Bacteria and Fungi Promote Coaggregation and
Formation of Mixed-Species Biofilms
Both singly and together, bacteria and fungi form highly
structured, often surface-associated, communities termed biofilms.
A significant proportion of human microbial infections are biofilm-
associated, wherein the formation of mixed-species biofilms could
create a protected environment that allows for survival to external
assaults and facilitates different bacterial-fungal interactions [1,2].
The known relationships between C. albicans and oral streptococci
illustrate the various ways by which bacteria and fungi can attach
to one another or coaggregate using specific cell surface factors,
leading to mixed-species biofilms [2,7]. These adhesive interac-
tions between C. albicans and other indigenous oral microbes can
be mediated by protein-protein and lectin-carbohydrate interac-
tions, and hydrophobic and electrostatic interactions may
contribute as well. C. albicans molecules such as agglutinin-like
sequences (Als) and specific cell surface glycoproteins have been
identified as being important for coadhesion to mixed microbial
communities in biofilms [1,10]. O’Sullivan and colleagues [11]
demonstrated that the oral bacterium Streptococcus gordonii adsorbs
salivary proline-rich proteins that are recognized by C. albicans and
act as receptors for the fungus (Figure 1A). Importantly, S. gordonii
cell surface polypeptides also contribute to coadherance with the
fungi [12]. Underscoring the complexity of these interactions,
adherence and coaggregation of C. albicans with oral bacteria is
species specific, and is mediated by bacterial receptors that might
be expressed only under particular environments.
Interdomain Signaling via Quorum-Sensing
Molecules and Other Microbial Products
Modulates Fungal and Bacterial Behavior
Single species bacterial and fungal populations modulate their
collective behavior using extracellular signals known as quorum-
sensing molecules [13,14]. Since this regulation generally occurs in
response to cell density, processes like co-aggregation and biofilm
formation promote the synthesis and secretion of quorum-sensing
molecules, increasing the likelihood that neighboring cells will
experience the signals at levels sufficient to induce a response.
Thus, the study of bacterial-fungal interactions in association with
mixed-species biofilms reveals that cross-kingdom communication
between bacteria and fungi is a common process, and that
quorum-sensing signals, known for their roles in intraspecies
communication, can also mediate crosstalk between bacteria and
fungi. C. albicans, as an illustration, induces its switch from hyphal
growth to yeast growth using a secreted quorum-sensing molecule
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PLoS Pathogens | www.plospathogens.org 1 April 2010 | Volume 6 | Issue 4 | e1000886Figure 1. An overview of how interactions between C. albicans and Gram-positive members of the human flora may influence
disease. (A) S. gordonii, a normal colonizer of the oral cavity, enhances C. albicans survival and persistence, thus contributing to the development of
C. albicans infections. In this environment, S. gordonii adhere to cells by expressing a complex repertoire of cell surface polypeptides (AgI/II) (a) that
recognize a range of host tissue proteins and cellular receptors [7]. After bacterial attachment, C. albicans can selectively attach to surface-bound
bacteria by means of protein-protein interactions [10,12] or by direct recognition of salivary proteins (basic proline-rich proteins, bPRPs) previously
adsorbed by S. gordonii cells [11] (b). Coaggregation of the bacterium and C. albicans contributes to biofilm formation and results in closer proximity
for cell-cell communication. Through a diffusible signal (DS) molecule (c), S. gordonii suppresses farnesol-mediated inhibition of hypha formation,
thereby enhancing the potential for C. albicans to form biofilms and thus its ability to invade tissue [7]. In addition, Streptococcus promotes (d) fungal
growth by secreting metabolic products that can be used as a carbon source by C. albicans [1]. Likewise, C. albicans enhances the survival and
colonization of S. gordonii by reducing the oxygen tension to levels preferred by streptococci and by providing bacterial growth stimulatory factors as
a result of nutrient metabolism [1,11]. These favorable conditions promote the formation of mature fungal-bacterial biofilms surrounded by an
extracellular matrix, to which (e) other bacterial or fungal species can bind. These interactions may make oral infections more persistent and hardert o
treat. (B) Lactobacillus sp., which normally inhabits the female reproductive tract, defends the host against colonization of pathogens such as C.
albicans. Evidence suggests that the bacterium reduces the adhesion of C. albicans to epithelial cells either by (a) outcompeting fungal cells for
PLoS Pathogens | www.plospathogens.org 2 April 2010 | Volume 6 | Issue 4 | e1000886called farnesol [14], which inhibits the Ras1-controlled pathway
involved in hyphal growth [15]. Strikingly, this small molecule can
also modulate bacterial behavior and virulence by altering the
production of toxic phenazines, such as pyocyanin in P. aeruginosa
[13]. Moreover, farnesol can also induce the generation of reactive
oxygen species in a number of microorganisms, likely through
effects on electron transport chain components [16], and this
process may play an important role in competition with bacteria.
Notably, a number of Gram-negative bacteria secrete molecules
with farnesol-like activities in that they induce a shift to yeast form
growth by the fungus [17]. For instance, P. aeruginosa–produced 3-
oxo-C12-homoserine lactone reaches concentrations in mixed-
species biofilms that repress C. albicans filamentation [17]. By
responding to these signaling molecules, the fungus may disperse
from sites where other co-inhabitants such as antifungal-producing
bacteria are present, conferring a potential selective advantage.
Conversely, in mixed biofilms of S. gordonii and C. albicans
(Figure 1A), a bacterially secreted diffusible signal enhances
hyphal development by relieving the effects of farnesol on the
fungus [7]. Moreover, cell wall–derived molecules such as bacterial
muramyl dipeptides induce C. albicans hyphal growth, which may
also promote fungal invasion of host tissues and virulence [18].
These findings support the concept that both eukaryotic and
prokaryotic microorganisms sense and respond to the diverse
diffusible signaling molecules produced in the niches where they
coexist. Furthermore, we may find that the chemical warfare
between bacteria and fungi leads to increased toxin production
and increased host damage and inflammation.
Chemical Interactions between Fungi and Bacteria
In addition to providing attachment sites for different species,
bacterial-fungal communities create environmental conditions that
promote or control the growth of other microbes. Actively
respiring C. albicans reduces oxygen tension levels and provides
stimulatory factors for streptococci in the oral environment, while
the latter provides nutrients that promote fungal growth [1]. In
contrast, commensal bacteria that inhabit the female reproductive
tract, such as Lactobacillus spp. (Figure 1B), inhibit the growth and
virulence of C. albicans potentially through secretion of organic
acids and production of hydrogen peroxide (H2O2). Supporting
these in vitro findings, it has been shown that 96% of healthy
women have H2O2-generating Lactobacillus species as part of their
microflora, while these bacterial populations are lower in women
suffering from vaginosis [8].
Bacterial-Fungal Interactions Influence Antibiotic
Resistance and Host Response to Infection
Mixed bacterial-fungal infections can correlate with increased
frequency or severity of disease. In fact, while C. albicans is the
fourth leading cause of mortality due to systemic infections [1,19],
the risk of mortality may increase upon bacterial and fungal co-
infection. C. albicans and Staphylococcus aureus, for instance, have
synergistic effects where mice inoculated with only S. aureus show
low mortality, whereas co-inoculation with C. albicans leads to
mortality increases [1,20]. It is not yet known how the host
immune response is perturbed when bacterial and fungal
pathogens are both present, but current research seeks to address
this important question. The cooperative effects observed in mixed
fungal-bacterial infections in vivo could be due to formation of
biofilms, since this form of growth can promote resistance to both
host clearance pathways and antimicrobial agents. Harriott and
Noverr demonstrated that the human pathogen S. aureus forms
larger biofilms with increased resistance to vancomycin when it is
co-cultured with C. albicans [19]. Biofilms of C. albicans and oral
streptococci are similarly more resistant to antibiotics than their
single species counterparts [1,2]. Matrix polymers produced by
both organisms might result in a more viscous matrix that is more
effective at restricting the penetration of drugs [2,19]. Under-
standing the physiology of bacteria and fungi coexisting within
mixed microbial communities will greatly aid our ability to
effectively treat opportunistic polymicrobial infections and to
modulate the behavior of potentially pathogenic bacteria and fungi
in beneficial ways.
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